DEK Is a Poly(ADP-Ribose) Acceptor in Apoptosis and Mediates Resistance to Genotoxic Stress
- 1 May 2008
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 28 (10) , 3245-3257
- https://doi.org/10.1128/mcb.01921-07
Abstract
DEK is a nuclear phosphoprotein implicated in oncogenesis and autoimmunity and a major component of metazoan chromatin. The intracellular cues that control the binding of DEK to DNA and its pleiotropic functions in DNA- and RNA-dependent processes have remained mainly elusive so far. Our recent finding that the phosphorylation status of DEK is altered during death receptor-mediated apoptosis suggested a potential involvement of DEK in stress signaling. In this study, we show that in cells committed to die, a portion of the cellular DEK pool is extensively posttranslationally modified by phosphorylation and poly(ADP-ribosyl)ation. Through interference with DEK expression, we further show that DEK promotes the repair of DNA lesions and protects cells from genotoxic agents that typically trigger poly(ADP-ribose) polymerase activation. The posttranslational modification of DEK during apoptosis is accompanied by the removal of the protein from chromatin and its release into the extracellular space. Released modified DEK is recognized by autoantibodies present in the synovial fluids of patients affected by juvenile rheumatoid arthritis/juvenile idiopathic arthritis. These findings point to a crucial role of poly(ADP-ribosyl)ation in shaping DEK's autoantigenic properties and in its function as a promoter of cell survival.Keywords
This publication has 65 references indexed in Scilit:
- Quantitative analysis of the binding affinity of poly(ADP-ribose) to specific binding proteins as a function of chain lengthNucleic Acids Research, 2007
- Activation of Poly(ADP)-ribose Polymerase (PARP-1) Induces Release of the Pro-inflammatory Mediator HMGB1 from the NucleusJournal of Biological Chemistry, 2007
- The DEK Nuclear Autoantigen Is a Secreted Chemotactic FactorMolecular and Cellular Biology, 2006
- The histone variant mH2A1.1 interferes with transcription by down-regulating PARP-1 enzymatic activityGenes & Development, 2006
- Apoptosis Inhibition by the Human DEK Oncoprotein Involves Interference with p53 FunctionsMolecular and Cellular Biology, 2006
- Intron Removal Requires Proofreading of U2AF/3' Splice Site Recognition by DEKScience, 2006
- DEK Expression is Controlled by E2F and Deregulated in Diverse Tumor TypeCell Cycle, 2006
- Regulation of histone acetyltransferase activity of p300 and PCAF by proto‐oncogene protein DEKFEBS Letters, 2006
- Poly(ADP‐ribose)The FEBS Journal, 2005
- The identification of novel therapeutic targets for the treatment of malignant brain tumorsCancer Letters, 2000